ALBIO — Biosynex SA Balance Sheet
0.000.00%
- €22.85m
- €75.51m
- €101.17m
- 41
- 77
- 18
- 38
Annual balance sheet for Biosynex SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 36.8 | 132 | 87.2 | 26.2 | 9.69 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17.3 | 34.7 | 33.6 | 21.3 | 17.5 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 87.5 | 199 | 160 | 91.4 | 64.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.36 | 5.26 | 8.74 | 16.1 | 14.9 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 126 | 269 | 260 | 242 | 195 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 49.1 | 67.3 | 39.7 | 51.4 | 90.9 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 59.8 | 101 | 97.8 | 117 | 114 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 66.3 | 168 | 163 | 124 | 80.6 |
Total Liabilities & Shareholders' Equity | 126 | 269 | 260 | 242 | 195 |
Total Common Shares Outstanding |